Biolife Sciences (Biolife Sciences) Liabilities-to-Assets : 1.14 (As of May. 2008)

Biolife Sciences Liabilities-to-Assets Chart

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Liabilities-to-Assets	Get a 7-Day Free Trial										0.94	0.94	0.98	1.06	1.14

Competitive Comparison of Biolife Sciences's Liabilities-to-Assets

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Liabilities-to-Assets falls into.

Biolife Sciences Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Biolife Sciences's Liabilities-to-Assets Ratio for the fiscal year that ended in Nov. 2007 is calculated as:

Biolife Sciences's Liabilities-to-Assets Ratio for the quarter that ended in May. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences  (OTCPK:BLFE) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Biolife Sciences Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description